ClinicalTrials.gov
ClinicalTrials.gov Menu

Effects of Atomoxetine on Cognitive Function in Schizophrenia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00420498
Recruitment Status : Completed
First Posted : January 11, 2007
Last Update Posted : December 12, 2007
Sponsor:
Collaborator:
National Alliance for Research on Schizophrenia and Depression
Information provided by:
Yale University

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : No date given
  Actual Study Completion Date : September 2007